Supplementary Figure S9 from Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer

Supplementary Figure S9. Number of copies of ctHPV DNA at different timepoints for all patients (n = 38) with only ctHPV DNA–negative samples at the end of treatment and early- and late follow-up who did not develop disease progression. Median follow-up time 37.5 months, range 18.3 – 50.0 months.